| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07180082 | Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer | Advanced Breast Cancer | Recruiting |
| NCT07180160 | Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative… | Advanced Breast Cancer | Recruiting |
| Not specified | |||
| NCT05876065 | Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer | Advanced Breast Cancer | Recruiting |
| NCT07180264 | Trastuzumab Deruxtecan in Advanced Breast Cancer | Advanced Breast Cancer | Recruiting |
| NCT07180056 | Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer | Breast Cancer | Recruiting |
| NCT07283718 | The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer… | Breast Cancer Invasive | Active, Not Recruiting |
| NCT07584213 | The Association Between Blood Routine Parameters and Breast Cancer Prognosis | Breast Cancer Invasive | Active, Not Recruiting |
| NCT07590570 | The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in… | Breast Cancer Invasive | Active, Not Recruiting |